+44 (0) 1425 463217







Covidien and GE Healthcare Collaboration Helps Enhance Clinical Decision-Making

May 3rd, Covidien and GE Healthcare, global providers of healthcare products and recognized innovators in patient monitoring and respiratory care devices, announced a five-year, global collaboration to incorporate Covidien measurement technologies into GE Healthcare patient monitors.

The Covidien collaboration reflects GE Healthcare’s commitment to maintain an open monitoring architecture, bringing together streams of patient data and making it usable for clinicians at the point of care. Integrated clinical information can provide valuable information for physicians, helping guide their decisions and enhance efficiency of care.

Matthias Weber, General Manager, Monitoring Solutions at GE Healthcare, said:

“GE Healthcare is committed to making a broad range of parameter measurements available on our powerful monitoring technology, including GE’s own SpO2 technology. Leveraging our 100-year history of designing life-critical devices, we are focused on delivering innovative clinical measurement technology. Such advances have the potential to support improved care, quality, and patient safety.”

Robert J. White, President of Covidien Respiratory and Monitoring Solutions, said:

“The advanced parameter portfolio from Covidien, coupled with GE Healthcare’s patient monitors, supports clinicians in detecting subtle but critical variations in a patient’s status. By delivering the full picture of a patient’s physiological status, patient safety and positive outcomes can be advanced.”